Your recommendation
Ozempic® GLP-1 injectable.
Ozempic® is a weekly weight loss injection clinically proven to help you lose up to 15% of your body weight. It works by regulating appetite, improving blood sugar control, and supporting long-term fat loss.
Ozempic® is a weekly weight loss injection clinically proven to help you lose up to 15% of your body weight. It works by regulating appetite, improving blood sugar control, and supporting long-term fat loss.
What’s included?
Medication
Ozempic®
Starting Dose
0.25mg
RM900 RM1,200 /month
Lose 15% of your body weight with our program
This branded weekly injection pen is a type of medication called GLP-1s. GLP-1s are a class of medical treatments for weight loss and diabetes. They mimic the GLP-1 hormone that is naturally released in the gastrointestinal tract in response to eating.
The active ingredient, Semaglutide, has been linked to deliver:
- Less hunger
- Fewer food cravings
- Better control of eating
- Reduced preference for high-fat foods
All this can lead to eating fewer calories and as a result, significant weight loss.
However, clinical research from studies of these medications have been proven to successfully reduce body weight by 15% over 12 months.
They have been proven to be almost 7 times more effective than diet and exercise alone.
Results vary from person to person especially taking into account lifestyle and diet.
Ozempic® treatment starts at RM 900 per month. You will pay this price monthly regardless of what dose of medication you are on.
If you want to maximise your results with unlimited Doctor consultations, booster supplements and digital tracking tools explore our program. It costs RM 1200 per month.
Learn more about this here.
Treatment success stories
“Patients using GLP-1s have been proven to be more effective at losing weight than diet and exercise alone.”
Dr. Ben Jen Ng,
Chief Medical Officer
[1] Most people lose only 3% of body weight with diet and exercise alone. With clinically supported medical treatment, you could lose up to 15%. (Source: NEJM, 2022)